Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents

Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents
Author :
Publisher : National Academies Press
Total Pages : 87
Release :
ISBN-10 : 9780309180900
ISBN-13 : 0309180902
Rating : 4/5 (902 Downloads)

Book Synopsis Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents by : National Research Council

Download or read book Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents written by National Research Council and published by National Academies Press. This book was released on 2006-08-07 with total page 87 pages. Available in PDF, EPUB and Kindle. Book excerpt: The National Institute of Allergy and Infectious Diseases (NIAID) gives the highest priority to developing countermeasures against bioterrorism agents that are highly infective when dispersed in aerosol form. Developing drugs to prevent or treat illnesses caused by bioterrorism agents requires testing their effectiveness in animals since human clinical trials would be unethical. At the request of NIAID, the National Academies conducted a study to examine how such testing could be improved. Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents provides recommendations to researchers on selecting the kinds of animal models, aerosol generators, and bioterrorism agent doses that would produce conditions that most closely mimic the disease process in humans. It also urges researchers to fully document experimental parameters in the literature so that studies can be reproduced and compared. The book recommends that all unclassified data on bioterrorism agent studies-including unclassified, unpublished data from U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)-be published in the open literature. The book also calls on the U.S. Food and Drug Administration to improve the process by which bioterrorism countermeasures are approved based on the results of animal studies.


Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents Related Books

Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents
Language: en
Pages: 87
Authors: National Research Council
Categories: Political Science
Type: BOOK - Published: 2006-08-07 - Publisher: National Academies Press

DOWNLOAD EBOOK

The National Institute of Allergy and Infectious Diseases (NIAID) gives the highest priority to developing countermeasures against bioterrorism agents that are
Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents
Language: en
Pages: 87
Authors: National Research Council
Categories: Political Science
Type: BOOK - Published: 2006-09-07 - Publisher: National Academies Press

DOWNLOAD EBOOK

The National Institute of Allergy and Infectious Diseases (NIAID) gives the highest priority to developing countermeasures against bioterrorism agents that are
Giving Full Measure to Countermeasures
Language: en
Pages: 161
Authors: National Research Council
Categories: Political Science
Type: BOOK - Published: 2004-05-06 - Publisher: National Academies Press

DOWNLOAD EBOOK

In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be
Giving Full Measure to Countermeasures
Language: en
Pages: 160
Authors: National Research Council
Categories:
Type: BOOK - Published: 2004-04-06 - Publisher:

DOWNLOAD EBOOK

In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be
Animal Models for Assessing Countermeasures to Bioterrorism Agents
Language: en
Pages: 152
Authors: National Research Council
Categories: Science
Type: BOOK - Published: 2012-01-09 - Publisher: National Academies Press

DOWNLOAD EBOOK

The Transformational Medical Technologies (TMT) has been a unique component of the U.S. Department of Defense (DoD) medical biodefense efforts since 2006. Its m